1. Home
  2. BNED vs CMPX Comparison

BNED vs CMPX Comparison

Compare BNED & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barnes & Noble Education Inc

BNED

Barnes & Noble Education Inc

HOLD

Current Price

$12.16

Market Cap

399.5M

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$2.36

Market Cap

408.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNED
CMPX
Founded
1965
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
399.5M
408.8M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
BNED
CMPX
Price
$12.16
$2.36
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$14.57
AVG Volume (30 Days)
194.9K
2.9M
Earning Date
03-10-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
119.60
N/A
EPS
0.49
N/A
Revenue
$1,714,770,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$934.41
P/E Ratio
$24.74
N/A
Revenue Growth
6.50
N/A
52 Week Low
$5.90
$1.61
52 Week High
$14.75
$6.88

Technical Indicators

Market Signals
Indicator
BNED
CMPX
Relative Strength Index (RSI) 48.18 52.28
Support Level $11.56 $1.82
Resistance Level $13.09 $2.51
Average True Range (ATR) 0.48 0.13
MACD -0.03 -0.01
Stochastic Oscillator 39.11 42.86

Price Performance

Historical Comparison
BNED
CMPX

About BNED Barnes & Noble Education Inc

Barnes & Noble Education Inc is a contract operator of physical and virtual bookstores for college and university campuses and K-12 institutions across the United States. The company is also a textbook wholesaler and inventory management hardware and software provider. It offers course materials through physical and online bookstores, including new and used print textbooks, rental options, digital textbooks, and publisher-hosted digital courseware. Products are also offered directly to students through Textbooks.com. The majority of the company's revenue is derived from the sale of products through its bookstore locations, including virtual bookstores, and the bookstore affiliated e-commerce websites.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: